Shriners Hospitals for Children Enters Partnership to Advance Treatment for Genetic Conditions
Council member Shriners Hospitals for Children has entered into a new research affiliation to create new and further existing treatment options for children diagnosed with genetic orthopedic conditions.
The partnership, with the Farmington, CT location of another NEC member, Jackson Laboratory for Genomic Medicine (JAX), will allow almost two dozen Shriners-operated hospitals and outpatient locations to perform new DNA sequencing on samples obtained from families. In turn, JAX will utilize its new technology to work to develop new treatments and provide new information on these rare diseases by performing genomic data analysis and even mouse models.
“This research can bring hope to countless families, and we’re looking forward to working with Shriners Hospitals to help children around the world,” said Dr. Charles Lee, a scientific director and professor at Jackson Labs.
The Council commends Shriners Hospitals for Children for this exciting partnership to further the treatment of disease and further medical research in the field. Read more in the Hartford Business Journal.
Recently from the Blog
NEC Calls On Congress to Pass Corporate Diversity Bill